Received Aug 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | SC |
CAPVAXIVE was administered subcutaneously instead of intramuscularly. Soreness, redness with hot/warm to touch, lump/harden on the arm around the injection site, fatigue, and weakness in legs. Then readness hot/warm to touch has kept expanding further away from the injection site and the lump/harden area won't go away after a few days. This condition has been ongoing since late Wednesday, July 16, 2025 when this vaccine was administered.
high blood pressure, hypercholesterolemia
IC Losartan Potassium, IC Rosuvastatin Calcium
Cipro, house dust, ceder